Clarification on Nov. 4 Special Report
November 12th 2014In the November 4 Drug Topics’ Special Report (15 hospitals to be evaluated on insulin-pen safety), the headline and summary seemed to imply that the 15 hospitals had been singled out due to their unsafe practices with insulin pens. This is not the case. The hospitals were selected to participate in the ASHP’s Mentored Quality Improvement Impact Program for Insulin Pen Safety. Drug Topics regrets any misunderstanding.
VTE treatment regimens have similar outcomes
November 10th 2014Historically, unfractionated heparin (UFH) with a vitamin K antagonist has been the standard treatment for deep venous thrombosis (DVT) or pulmonary embolism. More recently, low-molecular-weight heparin (LMWH) combined with vitamin K antagonists has become the most common choice, but newer target-specific oral anticoagulants have widened the range of treatment options.
CVS expands its Project Health program
November 7th 2014Over the next four months, CVS’ Project Health wellness programs will provide more than $14 million in free health services to communities throughout the United States with significant numbers of uninsured or underinsured patients, the company recently announced.
CVS, Rite Aid blocking Apple Pay
November 5th 2014Apparently, not everyone is excited about Apple’s new smartphone payment system-Apple Pay. Both CVS and Rite Aid recently both blocked customers from using Apple Pay at its stores, as well as the tap-to-pay mobile payments systems Google Wallet and Softcard.